ISPD Catheter-related Infection Recommendations: 2023 Update

Abstract

Peritoneal dialysis (PD) catheter-related infections are important risk factors for catheter loss and peritonitis. The 2023 updated recommendations have revised and clarified definitions and classifications of exit site infection and tunnel infection. A new target for the overall exit site infection rate should be no more than 0.40 episodes per year at risk. The recommendation about topical antibiotic cream or ointment to catheter exit site has been downgraded. New recommendations include clarified suggestion of exit site dressing cover and updated antibiotic treatment duration with emphasis on early clinical monitoring to ascertain duration of therapy. In addition to catheter removal and reinsertion, other catheter interventions including external cuff removal or shaving, and exit site relocation are suggested. © The Author(s) 2023.

Description

Keywords

Antibacterial agents, Antibiotic prophylaxis, Catheter-related infections, Exit site infection, Ispd guideline, Peritoneal dialysis, Prevention, Treatment outcome, Anti-bacterial agents, Catheters, indwelling, Humans, Peritonitis, Risk factors, Amoxicillin plus clavulanic acid, Cefazolin, Cefuroxime, Chlorhexidine, Ciprofloxacin, Clindamycin, Cotrimoxazole, Gentamicin, Hypochlorite sodium, Levofloxacin, Moxifloxacin, Mupirocin, Povidone iodine, Rifampicin, Vancomycin, Antiinfective agent, Antibiotic therapy, Antimicrobial activity, Article, Bacterial growth, Burkholderia cepacia, Catheter infection, Catheter removal, Cauterization, Clinical monitoring, Erythema, Granuloma, Hemodialysis, Hospitalization, Human, Laparoscopy, Methicillin resistant staphylococcus aureus, Minimum inhibitory concentration, Outcome assessment, Pseudomonas aeruginosa, Randomized controlled trial (topic), Risk factor, Staphylococcus aureus, Wound healing, Indwelling catheter

Citation

Endorsement

Review

Supplemented By

Referenced By